Allspring Global Investments Holdings, LLC Immuneering Corp Transaction History

Allspring Global Investments Holdings, LLC

$59.4 Billion
Q2 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 25, 2022	SELL	$3.89 - $7.81 $32,088 - $64,424	-8,249 Closed	0 $0
Q1 2022 May 02, 2022	SELL	$6.47 - $16.99 $6,334 - $16,633	-979 Reduced 10.61%	8,249 $53,000
Q4 2021 Jan 28, 2022	BUY	$16.12 - $31.02 $148,755 - $286,252	9,228 New	9,228 $149,000

Others Institutions Holding IMRX

# of Institutions

Shares Held

9.65M

Call Options Held

Put Options Held

Ken Griffin Citadel Advisors LLC | Chicago, Il

1.88M
Shares

$5.01 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

1.07M
Shares

$2.85 Million
0.0% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

953K
Shares

$2.54 Million
0.0% of portfolio
Price T Rowe Associates Inc Baltimore, MD

859K
Shares

$2.29 Million
0.0% of portfolio
Goldman Sachs Group Inc New York, NY

742K
Shares

$1.97 Million
0.0% of portfolio

View Full List

About Immuneering Corp

Ticker IMRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,392,300
Market Cap $70.2M
Description
Immuneering Corporation, a biopharmaceutical company, focuses on the oncology and neuroscience product candidates. Its lead product candidates include IMM-1-104, a dual-MEK inhibitor to treat patients with cancer, including pancreatic, melanoma, colorectal, and non-small cell lung cancer caused by mutations of RAS and/or RAF; and IMM-6-415 to tr...

More about IMRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.

Account